Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$27,000.00
Exploring the Impact of Metabolic Dysfunction on Accelerated Brain Aging in Schizophrenia Patients
EF 2024-25
Résumé
Schizophrenia spectrum disorders (SSDs) are a group of chronic mental health conditions that affect 1% of the population and are associated with significant impairment in thinking, perception, and social functioning. These individuals are also at risk for metabolic disorders such as diabetes and obesity, which increase the risk of cardiovascular disease (CVD). Recent research suggests that these metabolic abnormalities may contribute to brain health, speeding up the brain's aging trajectory which is characterized by structural and functional changes that deviate from typical aging trajectories.BrainAGE is a measure of the gap between the biological age of the brain compared to the chronological age of the individual, calculated using brain imaging techniques. Individuals with SSDs often experience accelerated brain aging relative to healthy individuals, leading to deficits in cognition and poorer functional outcomes. While some studies have linked obesity and dyslipidemia to increased BrainAGE, the impact that other metabolic parameters have has yet to be investigated.This study aims to investigate which metabolic dysfunctions are the best predictors of accelerated brain aging in individuals with SSDs. Participants will undergo routine metabolic measures such as fasting glucose and lipid profile, cognitive assessments, as well as measurements of visceral adiposity which is correlated with CVD and metabolic conditions such as obesity and type II diabetes. The data will be used to generate multi-modal profiles that characterize the trajectories of brain aging. The results of this study may suggest early risk factors for accelerated brain aging in SSD, which can be used as a therapeutic target to address the metabolic and cognitive impairments in this population.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
530100
Name
Monaghan Chow Isabella
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring the Impact of Metabolic Dysfunction on Accelerated Brain Aging in Schizophrenia Patients
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Brain Aging; Brain Imaging; Cognitive Deficits; Metabolism; Obesity; Schizophrenia
Abstract
Schizophrenia spectrum disorders (SSDs) are a group of chronic mental health conditions that affect 1% of the population and are associated with significant impairment in thinking, perception, and social functioning. These individuals are also at risk for metabolic disorders such as diabetes and obesity, which increase the risk of cardiovascular disease (CVD). Recent research suggests that these metabolic abnormalities may contribute to brain health, speeding up the brain's aging trajectory which is characterized by structural and functional changes that deviate from typical aging trajectories.BrainAGE is a measure of the gap between the biological age of the brain compared to the chronological age of the individual, calculated using brain imaging techniques. Individuals with SSDs often experience accelerated brain aging relative to healthy individuals, leading to deficits in cognition and poorer functional outcomes. While some studies have linked obesity and dyslipidemia to increased BrainAGE, the impact that other metabolic parameters have has yet to be investigated.This study aims to investigate which metabolic dysfunctions are the best predictors of accelerated brain aging in individuals with SSDs. Participants will undergo routine metabolic measures such as fasting glucose and lipid profile, cognitive assessments, as well as measurements of visceral adiposity which is correlated with CVD and metabolic conditions such as obesity and type II diabetes. The data will be used to generate multi-modal profiles that characterize the trajectories of brain aging. The results of this study may suggest early risk factors for accelerated brain aging in SSD, which can be used as a therapeutic target to address the metabolic and cognitive impairments in this population.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Monaghan Chow, Isabella
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~